X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (574) 574
Book Review (162) 162
Publication (25) 25
Book / eBook (14) 14
Book Chapter (9) 9
Conference Proceeding (4) 4
Web Resource (2) 2
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (531) 531
female (518) 518
index medicus (496) 496
middle aged (232) 232
adult (213) 213
aged (198) 198
oncology (174) 174
cancer (160) 160
vulvar neoplasms - pathology (158) 158
obstetrics & gynecology (127) 127
vulvar cancer (125) 125
vulvar neoplasms - surgery (117) 117
human papillomavirus (113) 113
aged, 80 and over (98) 98
squamous-cell carcinoma (97) 97
cervical cancer (93) 93
vulvar neoplasms - epidemiology (90) 90
risk factors (89) 89
women (87) 87
vulvar neoplasms - virology (81) 81
abridged index medicus (80) 80
vulvar neoplasms - therapy (76) 76
papillomavirus infections (75) 75
male (74) 74
carcinoma, squamous cell - pathology (73) 73
vulvar neoplasms - prevention & control (72) 72
adolescent (68) 68
incidence (65) 65
carcinoma (62) 62
vulvar intraepithelial neoplasia (62) 62
papillomavirus infections - prevention & control (61) 61
retrospective studies (61) 61
vulvar neoplasms - diagnosis (61) 61
surgery (60) 60
papillomavirus infections - complications (56) 56
intraepithelial neoplasia (55) 55
prognosis (55) 55
hpv (53) 53
papillomavirus infections - epidemiology (53) 53
prevention (53) 53
treatment outcome (53) 53
vulva (52) 52
neoplasm staging (50) 50
obstetrics and gynecology (50) 50
uterine cervical neoplasms - prevention & control (49) 49
young adult (49) 49
human-papillomavirus (47) 47
papillomavirus infections - virology (47) 47
uterine cervical neoplasms - epidemiology (47) 47
prevalence (45) 45
diagnosis (44) 44
health aspects (44) 44
research (44) 44
vaccination (43) 43
care and treatment (42) 42
analysis (41) 41
hematology, oncology and palliative medicine (41) 41
squamous cell carcinoma (41) 41
risk (40) 40
uterine cervical neoplasms - virology (40) 40
management (39) 39
cervical-cancer (38) 38
carcinoma, squamous cell - surgery (37) 37
lesions (36) 36
vulva - pathology (36) 36
vaccines (35) 35
carcinoma in situ - pathology (34) 34
vaginal neoplasms - epidemiology (34) 34
vulvar neoplasms (34) 34
vaginal neoplasms - virology (32) 32
natural-history (31) 31
vulvar neoplasms - mortality (31) 31
anus neoplasms - epidemiology (30) 30
carcinoma, squamous cell - epidemiology (30) 30
follow-up studies (30) 30
vulvar neoplasms - etiology (30) 30
age factors (29) 29
epidemiology (29) 29
lymph node excision (29) 29
medical research (29) 29
united states - epidemiology (29) 29
anus neoplasms - virology (28) 28
infection (28) 28
medicine, general & internal (28) 28
neoplasm recurrence, local - prevention & control (28) 28
vaginal neoplasms - prevention & control (28) 28
carcinoma, squamous cell - therapy (27) 27
dermatology (27) 27
genital cancers (27) 27
gynecology (27) 27
cervical intraepithelial neoplasia (26) 26
combined modality therapy (26) 26
human-papillomavirus infection (26) 26
medicine & public health (26) 26
neoplasm invasiveness (26) 26
papillomaviridae - isolation & purification (26) 26
papillomavirus vaccines - administration & dosage (26) 26
uterine cervical neoplasms - pathology (26) 26
vagina (26) 26
gynecologic-oncology-group (25) 25
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (546) 546
German (20) 20
French (6) 6
Polish (6) 6
Spanish (4) 4
Bulgarian (3) 3
Italian (3) 3
Chinese (2) 2
Dutch (2) 2
Portuguese (2) 2
Czech (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the National Cancer Institute, ISSN 0027-8874, 02/2013, Volume 105, Issue 3, pp. 175 - 201
The American Cancer Society (ACS), the Centers for Disease Control and Prevention (CDC), the National Cancer Institute (NCI), and the North American... 
United States - epidemiology | Age Distribution | Asian Americans - statistics & numerical data | Humans | Uterine Cervical Neoplasms - epidemiology | Cost of Illness | Anus Neoplasms - virology | Hispanic Americans - statistics & numerical data | Male | Neoplasms - prevention & control | Cause of Death | Incidence | Indians, North American - statistics & numerical data | Penile Neoplasms - epidemiology | Neoplasms - virology | Neoplasms - ethnology | Female | Anus Neoplasms - epidemiology | Papillomavirus Vaccines - administration & dosage | Penile Neoplasms - virology | Papillomavirus Infections - complications | SEER Program | Papanicolaou Test | Papillomavirus Infections - epidemiology | Neoplasms - mortality | Papillomavirus Infections - ethnology | Vulvar Neoplasms - virology | Mortality - trends | Oropharyngeal Neoplasms - virology | Vaginal Neoplasms - virology | Vaginal Smears - statistics & numerical data | Alphapapillomavirus | Oropharyngeal Neoplasms - epidemiology | African Americans - statistics & numerical data | Oceanic Ancestry Group - statistics & numerical data | Vaginal Neoplasms - epidemiology | Adolescent | Vulvar Neoplasms - epidemiology | Sex Distribution | Uterine Cervical Neoplasms - virology | Neoplasms - epidemiology | Prevention | Control | Forecasts and trends | Papillomavirus infections | Patient outcomes | Mortality | Index Medicus
Journal Article
BMJ, ISSN 0959-8138, 2010, Volume 341, Issue 7766, pp. 239 - 239
Objectives To evaluate the prophylactic efficacy of the human papillomavirus (HPV) quadrivalent vaccine in preventing low grade cervical, vulvar, and vaginal... 
Warts | RESEARCH | Lesions | Neoplasia | Population control | Vaccination | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | PARTICLE VACCINE | EXTERNAL GENITAL WARTS | CLINICAL-TRIALS | PREVENTION | TERMINOLOGY | INFECTION | HEALTH | CANCER | LESIONS | Double-Blind Method | Humans | Uterine Cervical Neoplasms - prevention & control | Treatment Outcome | Carcinoma in Situ - prevention & control | Condylomata Acuminata - prevention & control | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | Young Adult | Papillomavirus Infections - prevention & control | Vaginal Neoplasms - prevention & control | Cancer Vaccines | Vulvar Neoplasms - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Adult | Female | Urogenital Neoplasms - prevention & control | Papillomavirus Vaccines | Clinical trials | Human papillomavirus | Vaccines | Womens health | Index Medicus | Abridged Index Medicus | Papillomavirus Infections: prevention & control | Basic Medicine | Condylomata Acuminata: prevention & control | Medical and Health Sciences | Medicin och hälsovetenskap | Urogenital Neoplasms: prevention & control | Mikrobiologi inom det medicinska området | Uterine Cervical Neoplasms: prevention & control | Vaginal Neoplasms: prevention & control | Carcinoma in Situ: prevention & control | Microbiology in the medical area | Cervical Intraepithelial Neoplasia: prevention & control | Medicinska och farmaceutiska grundvetenskaper | Vulvar Neoplasms: prevention & control
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 06/2015, Volume 107, Issue 6, pp. djv086 - djv086
Background: This study sought to determine the prevaccine type-specific prevalence of human papillomavirus (HPV)-associated cancers in the United States to... 
UNITED-STATES | HUMAN-PAPILLOMAVIRUS TYPES | WORLDWIDE | IMPACT | ATTRIBUTION | ONCOLOGY | INVASIVE CERVICAL-CANCER | INFECTION | PREVALENCE | INTRAEPITHELIAL NEOPLASIA | VACCINATION COVERAGE | United States - epidemiology | Humans | Middle Aged | DNA, Viral - isolation & purification | Male | Neoplasms - prevention & control | Alphapapillomavirus - isolation & purification | Neoplasms - virology | Human papillomavirus 16 - isolation & purification | Adult | Female | Papillomavirus Infections - virology | Registries | Papillomavirus Vaccines - administration & dosage | Penile Neoplasms - virology | Papillomavirus Infections - complications | Penile Neoplasms - prevention & control | Uterine Cervical Neoplasms - prevention & control | Vulvar Neoplasms - virology | Oropharyngeal Neoplasms - virology | Laryngeal Neoplasms - prevention & control | Human papillomavirus 18 - isolation & purification | Alphapapillomavirus - genetics | Papillomavirus Infections - prevention & control | Vulvar Neoplasms - prevention & control | Uterine Cervical Neoplasms - virology | Oropharyngeal Neoplasms - prevention & control | Papillomavirus Vaccines - immunology | Aged | Laryngeal Neoplasms - virology | Papillomaviruses | Causes of | Genetic aspects | Health aspects | Identification and classification | Cancer | Human papillomavirus | Demographics | Vaccines | Medical diagnosis | Index Medicus
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2015, Volume 51, Issue 13, pp. 1732 - 1741
Abstract Objective Human papillomavirus (HPV) vaccines can potentially control cervical cancer and help to reduce other HPV-related cancers. We aimed to... 
Hematology, Oncology and Palliative Medicine | Papillomavirus vaccines | Human papillomavirus | Vulvar neoplasms | Vaginal neoplasms | Uterine cervical neoplasms | Precancerous conditions | Anus neoplasms | GLOBAL BURDEN | INFECTIONS | Uterine cervical neo-plasms | VACCINE | PREVALENCE | INTRAEPITHELIAL NEOPLASIA | WORLDWIDE | ONCOLOGY | SQUAMOUS-CELL CARCINOMA | INVASIVE CERVICAL-CANCER | VULVA | Predictive Value of Tests | Age Distribution | Age Factors | Humans | Middle Aged | Anus Neoplasms - prevention & control | Anus Neoplasms - virology | Papillomaviridae - genetics | Papillomavirus Infections - diagnosis | Uterine Cervical Dysplasia - diagnosis | Young Adult | Papillomaviridae - immunology | Uterine Cervical Dysplasia - virology | Vaginal Neoplasms - prevention & control | Aged, 80 and over | Adult | Female | Papillomavirus Infections - virology | Vulvar Neoplasms - diagnosis | Retrospective Studies | Uterine Cervical Neoplasms - diagnosis | Cross-Sectional Studies | Uterine Cervical Neoplasms - prevention & control | Cervical Intraepithelial Neoplasia - diagnosis | Vulvar Neoplasms - virology | Uterine Cervical Dysplasia - prevention & control | Vaginal Neoplasms - virology | Cervical Intraepithelial Neoplasia - virology | Anus Neoplasms - diagnosis | Papillomavirus Infections - prevention & control | Papillomaviridae - classification | Vulvar Neoplasms - prevention & control | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | Papillomavirus Vaccines - immunology | Aged | Human Papillomavirus DNA Tests | DNA, Viral - genetics | Vaginal Neoplasms - diagnosis | Papillomaviruses | Genetic aspects | Papillomavirus infections | Cervical cancer | Index Medicus
Journal Article
Sexually Transmitted Infections, ISSN 1368-4973, 11/2012, Volume 88, Issue 7, pp. 517 - 521
Objectives To obtain health-related quality of life valuations (ie, utilities) for human papillomavirus (HPV)-related cancer health states of vulval, vaginal,... 
UNITED-STATES | HEAD | INFECTIOUS DISEASES | LONG-TERM SURVIVORS | OROPHARYNX | MANAGEMENT | SQUAMOUS-CELL CARCINOMA | RADIOTHERAPY | BURDEN | NECK-CANCER | EPIDEMIOLOGY | Vaginal Neoplasms - psychology | Humans | Middle Aged | Anus Neoplasms - prevention & control | Anus Neoplasms - virology | Male | Oropharyngeal Neoplasms - psychology | Oropharyngeal Neoplasms - pathology | Anus Neoplasms - psychology | Young Adult | Vulvar Neoplasms - pathology | Penile Neoplasms - pathology | Penile Neoplasms - psychology | Vaginal Neoplasms - prevention & control | Adult | Female | Surveys and Questionnaires | Penile Neoplasms - virology | Papillomavirus Infections - complications | Penile Neoplasms - prevention & control | Vaginal Neoplasms - pathology | Vulvar Neoplasms - virology | Anus Neoplasms - pathology | Oropharyngeal Neoplasms - virology | Patient Acceptance of Health Care - statistics & numerical data | Health Knowledge, Attitudes, Practice | Vaginal Neoplasms - virology | Papillomavirus Infections - prevention & control | Vulvar Neoplasms - prevention & control | Adolescent | Quality of Life | Oropharyngeal Neoplasms - prevention & control | Aged | Vulvar Neoplasms - psychology | Papillomaviruses | Prevention | Causes of | Host-virus relationships | Health aspects | Papillomavirus infections | Risk factors | Quality of life | Studies | Human papillomavirus | Cervical cancer | Index Medicus | oral sex | attitudes | oral cavity | Anogenital cancer | Health Services Research | 1506 | oncology | HPV | vaccination
Journal Article
Sexual Health, ISSN 1448-5028, 2010, Volume 7, Issue 3, pp. 244 - 252
Although the human papillomavirus (HPV) vaccine was introduced primarily as a cervical cancer prevention vaccine, HPV has a causal role in several types of... 
Australia | HPV vaccine | cervical cancer | UNITED-STATES | INFECTIOUS DISEASES | METAANALYSIS | PREVENTION | CERVICAL-CANCER | PREVALENCE | INTRAEPITHELIAL NEOPLASIA | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | ANAL CANCER | SEXUAL PRACTICES | SQUAMOUS-CELL CARCINOMAS | PENILE CANCER | Age Factors | Humans | Middle Aged | Uterine Cervical Neoplasms - epidemiology | Anus Neoplasms - prevention & control | Male | Human papillomavirus 18 | Incidence | Penile Neoplasms - epidemiology | Young Adult | Human papillomavirus 16 | Sexually Transmitted Diseases, Viral - epidemiology | Vaginal Neoplasms - prevention & control | Adult | Female | Anus Neoplasms - epidemiology | Cervical Intraepithelial Neoplasia - epidemiology | Child | Papillomavirus Vaccines - administration & dosage | Cross-Sectional Studies | Carcinoma, Squamous Cell - epidemiology | Papanicolaou Test | Penile Neoplasms - prevention & control | Papillomavirus Infections - epidemiology | Uterine Cervical Neoplasms - prevention & control | Vaginal Smears | Carcinoma, Squamous Cell - prevention & control | Oropharyngeal Neoplasms - epidemiology | Vaginal Neoplasms - epidemiology | Cross-Cultural Comparison | Papillomavirus Infections - prevention & control | Vulvar Neoplasms - prevention & control | Adolescent | Sex Factors | Sexually Transmitted Diseases, Viral - prevention & control | Vulvar Neoplasms - epidemiology | Cervical Intraepithelial Neoplasia - prevention & control | Oropharyngeal Neoplasms - prevention & control | Aged | Developing Countries | Population Surveillance
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2014, Volume 9, Issue 2, pp. e88323 - e88323
Background: Infection with high-risk human papillomavirus (HPV) is causally related to cervical, vulvar and vaginal pre-invasive neoplasias and cancers. Highly... 
HPV-VACCINATION PROGRAM | WOMEN | POPULATION | METAANALYSIS | MULTIDISCIPLINARY SCIENCES | RISK | 4 NORDIC COUNTRIES | GENITAL WARTS | PREVALENCE | INTRAEPITHELIAL NEOPLASIA | LESIONS | Humans | Middle Aged | Uterine Cervical Neoplasms - epidemiology | Uterine Cervical Neoplasms - pathology | Incidence | Young Adult | Human papillomavirus 16 - isolation & purification | Vulvar Neoplasms - pathology | Vaginal Neoplasms - prevention & control | Adult | Cervix Uteri - pathology | Female | Papillomavirus Infections - virology | Vagina - pathology | Papillomavirus Vaccines - therapeutic use | Cervix Uteri - virology | Papillomavirus Infections - epidemiology | Uterine Cervical Neoplasms - prevention & control | Vaginal Neoplasms - pathology | Vulvar Neoplasms - virology | Vulva - virology | Vaginal Neoplasms - virology | Human papillomavirus 18 - isolation & purification | Vaginal Neoplasms - epidemiology | Papillomavirus Infections - prevention & control | Vulvar Neoplasms - prevention & control | Vagina - virology | Vulvar Neoplasms - epidemiology | Uterine Cervical Neoplasms - virology | Aged | Vulva - pathology | Papillomaviruses | Cancer vaccines | Medical research | Vaccination | Medicine, Experimental | Diagnosis | Papillomavirus infections | Cervical cancer | Cancer | Immunization | Risk groups | Laboratories | Invasiveness | Health risks | Vagina | Risk | Vaccines | Cervix | Medical diagnosis | Literature reviews | Human papillomavirus | Surveillance | Quality | Lesions | Health risk assessment | Public health | Age | Index Medicus | Basic Medicine | Medical and Health Sciences | Microbiology in the medical area | Mikrobiologi inom det medicinska området | Medicin och hälsovetenskap | Medicinska och farmaceutiska grundvetenskaper
Journal Article
Vaccine, ISSN 0264-410X, 2012, Volume 30, Issue 42, pp. 6016 - 6019
Highlights ► We estimated the annual direct medical costs attributable to HPV in the USA. ► The overall annual direct medical cost burden was estimated to be... 
Allergy and Immunology | Genital warts | Human papillomavirus | Health economics | Intraepithelial neoplasia | Cost | Vulvar, vaginal, anal, oral cavity, oropharyngeal, and cervical cancer | MEDICINE, RESEARCH & EXPERIMENTAL | POPULATION | IMMUNOLOGY | US HEALTH PLAN | CANCER SCREENING RATES | IMPACT | RECURRENT RESPIRATORY PAPILLOMATOSIS | HPV VACCINE | BURDEN | BENEFITS | Early Detection of Cancer - economics | United States - epidemiology | Papillomavirus Vaccines - economics | Humans | Papillomavirus Infections - epidemiology | Uterine Cervical Neoplasms - epidemiology | Respiratory Tract Infections - prevention & control | Uterine Cervical Neoplasms - prevention & control | Condylomata Acuminata - epidemiology | Cost of Illness | Respiratory Tract Infections - economics | Condylomata Acuminata - prevention & control | Papillomavirus Infections - economics | Oropharyngeal Neoplasms - epidemiology | Papillomavirus Infections - prevention & control | Health Care Costs - statistics & numerical data | Uterine Cervical Neoplasms - economics | Condylomata Acuminata - economics | Female | Oropharyngeal Neoplasms - prevention & control | Oropharyngeal Neoplasms - economics | Respiratory Tract Infections - epidemiology | Prevention | Warts | Papillomaviruses | Sexually transmitted diseases | Oncology, Experimental | Research | Papillomavirus infections | Cervical cancer | Cancer | Medical care, Cost of | Vaccines | Medical screening | Womens health | Index Medicus | Economics | Penis | Vaccination | Vagina | Papilloma | oropharyngeal cancer | Anogenital | genital warts | cost | intraepithelial neoplasia | vulvar | anal | oral cavity | vaginal | health economics
Journal Article
BMJ, ISSN 0959-8138, 3/2012, Volume 344, Issue 7851, pp. 16 - 16
Journal Article